Baseline characteristics of the North American prodromal Synucleinopathy cohort is a dataset published in Annals of Clinical and Translational Neurology (2023). On theSindex it has a DataRank of 1.1, placing it in the top 18.3% of the data-sharing corpus. It has been cited 48 times, with 26 citing works in its 1-hop citation network.
Ranks in the top 18% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.584
From this paper's citation signal
Citation Network Contribution
0.526
From 18 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 26 citers.
RRD VA
Grant: IK2 RX002947
U.S. Department of Veterans Affairs
Grant: 1K2 RX002947
NIA NIH HHS
Grant: R34 AG056639
NIA NIH HHS
Grant: U19 AG071754
NIA NIH HHS
Grant: P30 AG062677
NIA NIH HHS
Grant: P50 AG016574
National Institutes of Health
Grant: 5P30AG062677-02
Mayo Alzheimer's Disease Research Center
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1U19AG071754-01
North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2)
National Institutes of Health
Grant: 3P50AG016574-06S1
Mayo Alzheimers Disease Research Center
National Institutes of Health
Grant: 5R34AG056639-02
Neuroprotective Treatment Trial Planning in REM Sleep Behavior Disorder
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals